Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 10,000 shares at $67.17 ($672K) on 2024-03-08, disclosed to the SEC on 2024-03-11.
Scheduled sale ($672k) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |